Agoracom Blog Home

Posts Tagged ‘Delta-X Global Corp.’

Universal PropTech $UPI $UPIPF CGO Talks Explosive Covid-19 Diagnostics Market, Clinical Trials, & More $AAT.ca $LPS.ca $EGT.ca

Posted by AGORACOM at 5:16 PM on Thursday, May 13th, 2021
This image has an empty alt attribute; its file name is SMS-Smalljpg-1.jpg

Whereas many companies are just now trying to capitalize on the opportunities presented in the current and massive future of PropTech, Universal PropTech Inc. is actually delivering healthy building solutions and services for developers, owners, and operators in Canada. They’ve also turned their attention towards the global COVID-19 diagnostics market size, which is estimated at USD$84.4 billion in 2020.

We sat down with Frank Carnevale, CGO of Universal Proptech, to talk about the launch of ISBRG Corp’s SpotLight-19(C) clinical trial and new R&D funding, the global COVID-19 diagnostics market, their marketing/distribution plans for the future, and more. Check out the interview now.

Universal PropTech $UPI Now Listed on the #OTCQB Under the Symbol $UPIPF $AAT.ca $LPS.ca $EGT.ca

Posted by AGORACOM-JC at 4:07 PM on Tuesday, April 20th, 2021
  • Received approval and will begin trading on the OTCQB, a U.S. market operated by OTC Markets Group Inc. in New York
  • The Company’s shares will begin trading on the OTCQB on April 21, 2021, under the symbol “UPIPF”

Toronto, Ontario–(April 20, 2021) –  Universal PropTech Inc. (TSXV: UPI) (FSE:8LH) (“UPI” or the “Company“) is pleased to announce that it has received approval and will begin trading on the OTCQB, a U.S. market operated by OTC Markets Group Inc. (“OTC“) in New York. The Company’s shares will begin trading on the OTCQB on April 21, 2021, under the symbol “UPIPF”.

Chris Hazelton, CEO of Universal PropTech commented: “We are excited to begin trading in the United States, and we welcome the opportunity to share our story and journey with new investors.” Mr. Hazelton continued: “UPI provides an opportunity for investors to capitalize on growth opportunities created by our healthy building solutions, as well as investment and exclusive sales verticals for ISBRG Corp and their SpotLight19 platform.”

The OTC operates the world’s largest electronic interdealer quotation system for US broker dealers and offers multiple media channels to increase the visibility of OTC-listed companies. Trading on the OTCQB market enables companies to efficiently build broader investor awareness and provide U.S. investors with a seamless trading facility to more easily trade through the broker of their choice.

Read More: https://agoracom.com/ir/UniversalPropTech/forums/discussion/topics/759404-universal-proptech-inc-now-listed-on-the-otcqb-under-the-symbol-upipf/messages/2312771#message

Universal PropTech Inc. $UPI Announces Option Grant $AAT.ca $LPS.ca $EGT.ca

Posted by AGORACOM-JC at 4:42 PM on Friday, April 16th, 2021
  • Announces today that it has granted 100,000 options to an employee pursuant to the Company’s stock option plan.
  • The stock options vest in the following schedule: 30% immediately, 30% on the six-month anniversary of grant; and 40% on the one year anniversary of grant, and may be exercised at a price of $0.45 for a period of three years from the date of grant.
  • The grant of options is subject to the approval of the TSX Venture Exchange.

Toronto, Ontario–(April 16, 2021) – Universal PropTech Inc. (TSXV: UPI) (FSE: 8LH) (“UPI” or “the Company”) announces today that it has granted 100,000 options to an employee pursuant to the Company’s stock option plan. The stock options vest in the following schedule: 30% immediately, 30% on the six-month anniversary of grant; and 40% on the one year anniversary of grant, and may be exercised at a price of $0.45 for a period of three years from the date of grant. The grant of options is subject to the approval of the TSX Venture Exchange.

About Universal PropTech Inc.

Universal PropTech Inc. (TSXV: UPI) (FSE: 8LH ) is a leading building innovation company, selecting, integrating, deploying, and maintaining PropTech in healthy buildings. As trusted advisors, we provide holistic evidence-driven solutions and services for building developers, owners, and operators in Canada. UPI operates through its wholly owned subsidiary, VCI Controls Inc. (“VCI“), a leading supplier and integrator of PropTech healthy building solutions and services. VCI is an industry leader in the acquisition and deployment of intelligent building technology, including the integration of all building systems utilizing the latest in communications technologies and standards. VCI’s business focuses on digital controls and mechanical services, performance monitoring, and energy efficiency solutions.

With headquarters in Toronto, Universal PropTech Inc. has offices across Canada including, Halifax, Montreal, and Ottawa. For more information, visit www.universalproptech.com.

Contact Information
Universal PropTech Inc.

Chris Hazelton
President and Chief Executive Officer
[email protected]

(647) 300-2957

Forward-Looking Statements

Certain information provided in this press release constitutes forward-looking statements and information within the meaning of applicable securities laws. Forward-looking information typically contains statements with words such as “anticipate”, “believe”, “forecast”, expect”, “plan”, “intend”, “estimate”, “propose”, “project”, or similar words suggesting future outcomes. The Company cautions readers and prospective investors in the Company’s securities not to place undue reliance on forward-looking information as, by its nature, it is based on current expectations regarding future events that involve a number of assumptions, inherent risks and uncertainties, which could cause actual results to differ materially from those anticipated by the Company.

The forward-looking information included herein is expressly qualified in its entirety by this cautionary statement. The forward-looking information included herein is made as of the date hereof and the Company assumes no obligation to update or revise any forward-looking information to reflect new events or circumstances, except as required by law.

Neither the TSX Venture Exchange (“Exchange”), nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this release. No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein.

VIDEO – Universal PropTech $UPI CGO Frank Delves Into The Company’s Future $UPI.ca $AAT.ca $LPS.ca $EGT.ca

Posted by AGORACOM-JC at 4:33 PM on Tuesday, March 30th, 2021

VIDEO – An Introduction to Universal PropTech Inc. $UPI.ca $AAT.ca $LPS.ca $EGT.ca

Posted by AGORACOM-JC at 3:46 PM on Tuesday, March 30th, 2021

Universal PropTech $UPI Provides Update on SpotLight-19(C) – Designed to Detect COVID-19 in Under 20 Seconds and at a Cost of Approximately $1 Per Test $AAT.ca $LPS.ca $EGT.ca

Posted by AGORACOM-JC at 9:48 AM on Tuesday, March 9th, 2021
  • ISBRG Corp (“ISBRG“) has posted a number of updates on their website (www.isbrgcorp.com) regarding their SpotLight-19© Technology
  • Updated the expected COVID-19 detection time to under 20 seconds, at an approximate cost of $1 per COVID-19 test, an expanded list of solutions, and adding an additional advisor to the Advisory Board.

Toronto, Ontario–(March 9, 2021) –  Universal PropTech Inc. (TSXV:UPI) (FSE:8LH) (“UPI” or the “Company“) is pleased to announced that ISBRG Corp (“ISBRG“) has posted a number of updates on their website (www.isbrgcorp.com) regarding their SpotLight-19© Technology including updating the expected COVID-19 detection time to under 20 seconds, at an approximate cost of $1 per COVID-19 test, an expanded list of solutions, and adding an additional advisor to the Advisory Board.

ISBRG’s SpotLight-19© technology leverages advancements in optics and artificial intelligence to define a state of COVID-19 infection.

SpotLight-19© (which upon testing to establish specificity and sensitivity ISBRG intends to submit for regulatory approval) is designed to screen for a unique infectious state – within 20 seconds of scanning a fingertip with light. ISBRG is undertaking trials to determine SpotLight-19©’s efficacy in detecting COVID-19, and if proven effective, will be subject to further regulatory approvals before it would be commercially available.

The speed and estimated cost of the test (approximately one dollar), combined with the non-invasive nature of light (no body fluid of any kind is required), is intended to accommodate the testing of large numbers of people without the inconvenient delays and environmental damage associated with current chemical reagent-based tests.

Below is an image of a finger over the beam of light from ISBRG Corp’s SpotLight-19 device.

 ISBRG Corp’s SpotLight-19 device

To view an enhanced version of this graphic, please visit:
https://orders.newsfilecorp.com/files/5341/76555_e6bb61ceb4a639fe_002full.jpg

We are very excited that ISBRG has begun to inform the world of the high expectations for SpotLight-19,” commented Chris Hazelton, President and CEO of UPI. “Pending further testing and submission for regulatory approval, a 20-second COVID-19 test will open the global economy, and at an approximate cost of $1 per test, will enable governments around the world to afford and adopt rapid testing for COVID-19. We look forward to the results of ISBRG’s clinical trials and we have high hopes for its success. Once shown to be effective in testing for COVID-19, we expect other applications to follow.”

The global COVID-19 diagnostics market size is estimated at USD$84.4 billion in 2020 and is expected to expand at a compounded annual growth rate (CAGR) of 3.1% from 2021 to 2027[1].

In addition, the ISBRG website adds that ISBRG’s technology is designed for other applications, including for viral infection – screening technology to detect unique infections, including COVID-19; drug impairment – defining a unique state of impairment (such as THC); athletic fitness – defining a state of optimal fitness performance; nutritional health – defining the impact of dietary and / or supplement choices; healthy aging – defining the impact of gradual lifestyle changes and aging; and adolescent health – defining the impact of early stage lifestyle, exercise and nutrition decisions.

Read More: https://agoracom.com/ir/UniversalPropTech/forums/discussion/topics/756884-universal-proptech-inc-provides-update-on-spotlight-19c-designed-to-detect-covid-19-in-under-20-seconds-and-at-a-cost-of-approximately-1-per-test/messages/2307213#message

Universal PropTech $UPI Announces #OTC Application Filing $AAT.ca $LPS.ca $EGT.ca

Posted by AGORACOM-JC at 9:06 AM on Thursday, March 4th, 2021
  • Filed an application to be quoted on the OTCQB, a U.S. market operated by OTC Markets Group Inc. in New York.
  • The Company will continue to trade on the TSX Venture Exchange under its symbol “UPI” and the Frankfurt Stock Exchange under its symbol “8LH”.
  • In addition, the Company is working to secure DTC eligibility with The Depository Trust Company for electronic settlement and transfer of its common shares in the United States.

Toronto, Ontario–(March 4, 2021) – Universal PropTech Inc. (TSXV: UPI) (FSE: 8LH) (“UPI” or the “Company“) is pleased to announce that is has filed an application to be quoted on the OTCQB, a U.S. market operated by OTC Markets Group Inc. (“OTC“) in New York. The Company will continue to trade on the TSX Venture Exchange under its symbol “UPI” and the Frankfurt Stock Exchange under its symbol “8LH”. In addition, the Company is working to secure DTC eligibility with The Depository Trust Company (“DTC“) for electronic settlement and transfer of its common shares in the United States.

Chris Hazelton, CEO of Universal PropTech commented, “UPI is excited to provide US institutional and retail investors this opportunity to join our journey through the OTCQB.” Mr. Hazelton continued, “We love our Canadian roots, but our plans and visions include being traded in the largest economy on the planet and demonstrate our investment capabilities in technologies with global impacts, such as SpotLight19.”

The OTC operates the world’s largest electronic interdealer quotation system for US broker dealers and offers multiple media channels to increase the visibility of OTC-listed companies. Trading on the OTCQB market enables companies to efficiently build broader investor awareness and provide U.S. investors with a seamless trading facility to more easily trade through the broker of their choice.

Obtaining quotation of the Company’s common shares on the OTCQB remains subject to the approval of the OTCQB and the satisfaction of applicable listing requirements. The quotation of Universal PropTech shares is expected to begin upon securing the approval from the OTC. As more information becomes available, the Company will keep its shareholders up-to-date on the status of the application.

Read More: https://agoracom.com/ir/UniversalPropTech/forums/discussion/topics/756563-universal-proptech-inc-announces-otc-application-filing/messages/2306466#message

VIDEO – Universal PropTech $UPI Secures Investment and Rights To Finger Scan Test Designed To Detect COVID-19 In Less Than A Minute $AAT.ca $LPS.ca $EGT.ca

Posted by AGORACOM-JC at 6:04 PM on Thursday, February 18th, 2021

As the name implies “PropTech” is a combination of two words and stands for “property technology.”  As simple as that is, the implementation and importance of PropTech is anything but, which is why many companies are trying to capitalize on the rapidly growing paradigm shift, while Universal PropTech (UPI:TSXV) is actually delivering healthy building solutions developers, owners and operators across Canada. 

More than just lip service, UPI clients include:

· Federal Government facilities for over 40 years 

· Manulife 

· Brookfield 

· Billy Bishop Airport 

· University of Toronto 

· …. and many more 

As a result, UPI has generated $35,000,000+ in revenue over the past 3 year – a number most small cap companies would be very happy with.  But newly appointed Chief Growth Officer, Frank Carnevale sees a much bigger opportunity by winning exclusive licenses and partnerships with providers of great products that can significantly grow company revenues … and he has delivered pretty strongly against this mission statement in 2021. 

BUT TODAY HE TOOK A GIANT LEAP FORWARD 

The press release headline says it all:

Universal PropTech Inc. Invests in and Secures defined Agency Rights for ISBRG Corp.’s SpotLight-19(C) Technology Designed to Detect Covid-19 Non-Invasively in Under One Minute  

In short, this technology takes a non-invasive scan of a person’s finger with a harmless beam of light designed to provide confirmation of Covid-19 infection in less than 1 minute.  

How significant is this announcement and what does it mean to the Company’s growth? 

Watch our interview with CGO Carnevale to learn all about it. 

Universal PropTech $UPI Invests in and Secures defined Agency Rights for ISBRG Corp.’s SpotLight-19(C) Technology Designed to Detect Covid-19 Non-Invasively in Under One Minute $AAT.ca $LPS.ca $EGT.ca

Posted by AGORACOM-JC at 9:57 AM on Thursday, February 18th, 2021
  • ISBRG is a data analytics company which has developed the SpotLight technology platform designed to generate comprehensive health care data non-invasively within seconds at a nominal incremental cost per test.
  • SpotLight-19© is non-invasive, and ISBRG is undertaking trials to determine efficacy in detecting Covid-19.
  • In addition to its minority investment, UPI will act as the exclusive sales agent for the SpotLight-19© technology and other future platform offerings for the government and education sectors in Canada.

Toronto, Ontario–(February 18, 2021) – Universal PropTech Inc. (TSXV: UPI) (“UPI” or the “Company”) is pleased to announce that it has completed an investment in ISBRG Corp. (“ISBRG”) for a minority interest, and secured agency rights to their SpotLight-19© Technology.

ISBRG is a data analytics company which has developed the SpotLight technology platform designed to generate comprehensive health care data non-invasively within seconds at a nominal incremental cost per test. SpotLight-19© is non-invasive, and ISBRG is undertaking trials to determine efficacy in detecting Covid-19. In addition to its minority investment, UPI will act as the exclusive sales agent for the SpotLight-19© technology and other future platform offerings for the government and education sectors in Canada.

“We are proud and excited to be a strategic investor in ISBRG,” stated Chris Hazelton, President & CEO of Universal PropTech. “We have been committed to ensuring safe and healthy workspaces for our clients and facilitating the return of workers to workspaces in the face of the pandemic, and SpotLight-19© as a rapid, inexpensive and reusable testing platform to ensure safe work environments, could be a catalyst to opening global economies. Upon completion of trials and relevant governmental approvals, Universal PropTech expects that it will aggressively market SpotLight-19© products and supporting services to all governmental and education providers across Canada.”

“Our technology stems from the belief that technological innovation and strategic partnerships will restore economic growth globally in the midst of a pandemic that is challenging the speed, accuracy and effectiveness of existing tests” stated Duncan MacIntyre, Founder and CEO ISBRG.

ISBRG’s SpotLight-19© technology platform has proof of concept, and the funding now enables trials to determine the sensitivity and specificity of the device which will be compared to the accuracy of PCR tests in upcoming trials which are subject to authorization by Health Canada and REB review. Several published studies support ISBRG’s proof of concept and the application of light to detect viruses has been well documented in the past, see (https://pubmed.ncbi.nlm.nih.gov/29806030/).

The global Covid-19 diagnostics market size is estimated at USD$84.4 billion in 2020 and is expected to expand at a compounded annual growth rate (CAGR) of 3.1% from 2021 to 2027[1].

ISBRG headquartered in Mississauga, Ontario, developed its SpotLight-19© technology platform to monitor health – including a Covid-19 state of infection – using patent pending proprietary applications utilizing machine learning, optics and non-invasive interface design.

SpotLight-19© technology platform features:

  • a non-invasive scan of a person’s finger with a harmless beam of light
  • designed to provide confirmation of Covid-19 infection in less than 1 minute
  • low-cost testing.

ISBRG’s SpotLight-19© technology is intended for use in large venues, such as:

  • airports
  • border crossings
  • government buildings
  • schools and campuses
  • entertainment complexes, etc.

Should your organization wish to express an interest in procuring SpotLight-19©, please link and complete the Contact form. https://universalproptech.com/

ISBRG founder Duncan MacIntyre, is the former President of ICI in Canada and Latin America, the founding President of the National Quality Institute and co-author of more than 25 US patents in the field of spectroscopy. He has assembled a team of medical doctors, Ai specialists, hardware designers, internationally recognized optics experts and an ISBRG Board of Advisors that excel in their respective fields. The Board of Advisors includes:

  • former Global VP of AMGEN – Michael Kelly
  • former Canadian Astronaut and Author – Commander Chris Hadfield
  • former Director of Emera and Order of Canada appointee – Irene d’Entremont
  • former President of American Eagle Airlines – Peter Bowler
  • former Director General Global Operations CSIS – Allan MacDougall

Michael Kelly, former AMGEN Global VP, Thousand Oaks, California, states: “I became involved in ISBRG because of SpotLight-19©’s Ai and optical design innovations which, subject to confirmation in these trials, have the potential to significantly impact the global economic recovery more than any other technology available today”.

Read More: https://agoracom.com/ir/UniversalPropTech/forums/discussion/topics/755586-universal-proptech-inc-invests-in-and-secures-defined-agency-rights-for-isbrg-corp-s-spotlight-19-c-technology-designed-to-detect-covid-19/messages/2304191#message

VIDEO – Universal PropTech $UPI Has Generated $35,000,000+ In Revenues Over Past 3 Years – But Chief Growth Officer Carnevale Sets Up For Big Growth In 2021 $AAT.ca $LPS.ca $EGT.ca

Posted by AGORACOM-JC at 5:29 PM on Thursday, February 11th, 2021

As the name implies “PropTech” is a combination of two words and stands for “property technology.”  As simple as that is, the implementation and importance of PropTech is anything but, which is why many companies are trying to capitalize on the rapidly growing paradigm shift, while Universal PropTech (UPI:TSXV) is actually delivering healthy building solutions developers, owners and operators across Canada.

More than just lip service, UPI clients include

  • Federal Government facilities for over 40 years
  • Manulife
  • Brookfield
  • Billy Bishop Airport
  • University of Toronto
  • …. and many more

As a result, UPI has generated $35,000,000+ in revenue over the past 3 year – a number most small cap companies would be very happy with.  But newly appointed Chief Growth Officer, Frank Carnevale sees a much bigger opportunity by winning exclusive licenses and partnerships with providers of great products that can significantly grow company revenues. 

And that’s exactly what he has done.  In the month of FEBRUARY alone, UPI has announced:

 Agreement with LuminUltra Technologies to Provide SARS-CoV-2 (COVID-19) Surface Testing

Channel Partnership with SensorSuite Inc. to Deliver AI Building Automation for MURBs and Non-BAS Customers

Exclusive Distributor Agreement for Eastern Canada for Canadian-Made Air Sanitization Solutions

How significant are these announcements and what do they mean to the Company’s growth?  

Watch our interview with CGO Carnevale to learn about these and where UPI is going.